Citations

Clear

2358 citation(s) found for "Yu, Long".

Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer
Annibali, Daniela , Ashton, Katie A. , Auer, Paul L. , Beckmann, Matthias W. , Black, Amanda , Brinton, Louise A. , Buchanan, Daniel D. , Chen, Chu , Chen, Maxine , Cheng, Timothy, Crous‐Bou, Marta , Vivo, Immaculata De , Dörk, Thilo , Dowdy, Sean C. , Easton, Douglas F. , Ekici, Arif B. , Fasching, Peter A. , García‐Closas, Montserrat , Gaudet, Mia M. , Goode, Ellen L. , Gorman, Maggie, Haiman, Christopher A. , Hankinson, Susan E. , Hein, Alexander , Hillemanns, Peter , Hodgson, Shirley, Høivik, Erling A. , Holliday, Elizabeth , Hunter, David J., Lambrechts, Diether , Liang, Xiaolin , Lindblom, Annika , Lissowska, Jolanta , Magliocco, Anthony M., Martin, Lynn , McEvoy, Mark , Mints, Miriam, Nassir, Rami , Otton, Geoffrey, Palles, Claire , Pooler, Loreall , Proietto, Tony, Rübner, Matthias, Runnebaum, Ingo B. , Sacerdote, Carlotta , Sarto, Gloria E., Scott, Rodney J. , Shah, Mitul , Sheng, Xin , Tomlinson, Ian , Trovik, Jone , Wang, Zhaoming , Wentzensen, Nicolas , Xia, Lucy , Webb, Penelope M. , Thompson, Deborah J. , Glubb, Dylan M., O’Mara, Tracy A. , Lambrechts, Diether , Buchanan, Daniel D , Chen, Chu , De Vivo, Immaculata , Dörk, Thilo , Fasching, Peter A , Friedenreich, Christine M , Gaudet, Mia M , Goode, Ellen L , Lu, Lingeng , Sacerdote, Carlotta , Shu, Xiao-Ou , Wang, Zhaoming , Wentzensen, Nicolas , Xiang, Yong‐Bing , Yu, Herbert , Spurdle, Amanda B , O'Mara, Tracy A , Lambrechts, Diether , Webb, Penelope M , Hein, Alexander , Hillemanns, Peter , Lissowska, Jolanta , Lambrechts, Diether , García-Closas, Montserrat , Ekici, Arif B , Nassir, Rami , Palles, Claire , Lindblom, Annika , Kho, Pik Fang , Amant, Frédéric , Attia, John , Chanock, Stephen Jacob , Cook, Linda S. , Czene, Kamila , Dennis, Joe , Dunning, Alison M. , Dürst, Matthias , Fridley, Brooke L. , Giles, Graham G. , Hall, Per N , Hankinson, Susan E. , Jones, Angela, Kraft, Peter , Krakstad, Camilla , Marchand, Loı̈c Le , Long, Jirong , Milne, Roger L. , Mints, Miriam , Rebbeck, Timothy R. , Renner, Stefan P. , Risch, Harvey A. , Schumacher, Fredrick R. , Setiawan, Veronica Wendy , Shu, Xiao‐Ou , Southey, Melissa C. , Tham, Emma , Turman, Constance , Tyrer, Jonathan P. , Berg, David Van Den , Yang, Hannah , Yu, Kai , Zheng, Wei , Spurdle, Amanda B.

Mayo Clinic

International Journal of Cancer | July 13, 2020 | Volume: 148 | Issue: 2 | Pages: 307-319

10.1002/ijc.33206 | PMID 32851660 Get It

Abstract Blood lipids have been associated with the development of a range of cancers, including breast, lung and colorectal cancer. For endometrial cancer, observational studies have reported inconsistent associations between blood lipids and cancer risk. To reduce biases from unmeasured confounding, we performed a bidirectional, two‐sample Mendelian randomization analysis to investigate the relationship between levels of three blood lipids (low‐density lipoprotein [LDL] and high‐density lipoprotein [HDL] cholesterol, and triglycerides) and endometrial cancer risk. Genetic variants associated with each of these blood lipid levels ( P < 5 × 10 −8 ) were identified as instrumental variables, and assessed using genome‐wide association study data from the Endometrial Cancer Association Consortium (12 906 cases and 108 979 controls) and the Global Lipids Genetic Consortium (n = 188 578). Mendelian randomization analyses found genetically raised LDL cholesterol levels to be associated with lower risks of endometrial cancer of all histologies combined, and of endometrioid and non‐endometrioid subtypes. Conversely, higher genetically predicted HDL cholesterol levels were associated with increased risk of non‐endometrioid endometrial cancer. After accounting for the potential confounding role of obesity (as measured by genetic variants associated with body mass index), the association between genetically predicted increased LDL cholesterol levels and lower endometrial cancer risk remained significant, especially for non‐endometrioid endometrial cancer. There was no evidence to support a role for triglycerides in endometrial cancer development. Our study supports a role for LDL and HDL cholesterol in the development of non‐endometrioid endometrial cancer. Further studies are required to understand the mechanisms underlying these findings.
Performance of perpendicular drop versus tangent skimming gating of M-protein in proficiency testing challenges
Long, Thomas A., Bashleben, Christine , Fink, Susan L. , Rudolf, Joseph W. , Peterson, Daniel J. , Wener, Mark H. , Baltaro, Richard J., Genzen, Jonathan R. , Ansari, M. Qasim , Rhoads, Daniel D. , Rhoads, Daniel D , Willrich, Maria Alice V. , Linden, Michael A.

Mayo Clinic

Clinical Chemistry and Laboratory Medicine (CCLM) | July 10, 2020 | Volume: 59 | Issue: 1 | Pages: e19-e22

10.1515/cclm-2020-0697 | PMID 32628626 Get It

Long-term toxicity and survival outcomes after stereotactic ablative radiotherapy for patients with centrally located thoracic tumors
Atalar, Banu , Mustafayev, Teuta Zoto , Şahin, Bilgehan , Güngör, Görkem , Aydın, Gökhan , Yapıcı, Bülent, Özyar, Enis , Sio, Terence T.

Mayo Clinic

Radiology and Oncology | July 10, 2020 | Volume: 54 | Issue: 4 | Pages: 480-487

10.2478/raon-2020-0039 | PMID 32589607 Get It

Abstract Background Stereotactic ablative radiotherapy (SABR) is effective for thoracic cancer and metastases; however, adverse effects are greater for central tumors. We evaluated factors affecting outcomes and toxicities after SABR for patients with primary lung and oligometastatic tumors. Patients and methods We retrospectively identified consecutive patients with centrally located lung tumors that were treated at our hospital from 2009-2016. The effects of patient, disease, and treatment-related parameters on local control (LC), overall survival (OS), and toxicity-free survival (TFS) were evaluated with multivariate analyses. Results Among 65 consecutive patients identified with 70 centrally located tumors, 20 tumors (28%) were reirradiated. Median (range) total dose for all tumors was 55 (30–60) Gy in 5 (3–10) fractions. Radiographic complete response was obtained in 43 lesions (61%). None of the analyzed factors were correlated with complete response. After a median follow-up of 57 (95% CI, 48–65) months, 10 tumors (14%) relapsed and 37 patients (57%) died; the actuarial 2- and 5-year OS rates were 52% and 28%, respectively. Median OS was significantly lower in patients with grade 3 or higher toxicity vs . lower toxicity (5 vs . 39 months; P < 0.001). Among 17 severe toxicities, 5 were grade 5, and 3 of them were reirradiated to the same field. Grade 3 to 5 TFS was lower with vs . without reirradiation (2-year TFS, 63% vs . 96%; P = 0.02). Conclusions Our study showed that modern SABR is effective for central lung tumors, and toxicities are acceptable. SABR for reirradiated central lung lesions and possibly for lesions abutting the tracheobronchial tree may result in higher risk of serious toxicities.
An Emergent Bedside Surgical Airway Requiring Operating Room Revision
Awari, D., Long, T.

Mayo Clinic

C45. CRITICAL CARE CASE REPORTS: MECHANICAL VENTILATION FROM NIV TO ECMO | July 7, 2020 | Volume: No volume available | Issue: No issue available | Pages: A5196-A5196

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a5196 Get It

Bedside Visualization of Heart-Lung Interactions by Speckle Tracking Echocardiography: A Tale of Two Hearts
Long, C., Moraes, Adriano, Lin, Guan‐Ling , Oeckler, Richard A. , Wiley, Brandon M.

Mayo Clinic

B25. MECHANICAL VENTILATION AND ARDS: CLINICAL AND PHYSIOLOGICAL STUDIES | July 7, 2020 | Volume: No volume available | Issue: No issue available | Pages: A2886-A2886

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a2886 Get It

Short and Long Termoxygenation Outcomes After Liver Transplantation for Hepatopulmonary Syndrome
Pinto, Candida, Moraes, Adriano, Albitar, Hasan Ahmad Hasan , Almodallal, Yahya , Rosen, Charles B. , Taner, Timuçin , Nyberg, Scott L. , Cartin‐Ceba, Rodrigo , Krowka, Michael J. , DuBrock, Hilary M. , Cajigas, Héctor , Heimbach, Julie K. , Vargas, Hugo E. , Keaveny, Andrew P. , Iyer, Vivek

Mayo Clinic

B27. UP-TO-DATE PAH ASSESSMENT AND MANAGEMENT | July 7, 2020 | Volume: No volume available | Issue: No issue available | Pages: A2926-A2926

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a2926 Get It

Approach to Non-Invasive Ventilation in ARDS: A Single Center Survey
Long, C., Oeckler, Richard A. , Moraes, Alice Gallo de

Mayo Clinic

A40. CRITICAL CARE: FROM HFNC TO ECMO | July 7, 2020 | Volume: No volume available | Issue: No issue available | Pages: A1594-A1594

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a1594 Get It

Efficacy of Intentional Permanent Atrial Pacing in the Long-Term Management of Congenital Long QT Syndrome
Kowlgi, Gurukripa N. , Giudicessi, John R. , Barake, Walid , Ackerman, Michael J. , Kowlgi, Narayan G , Bos, J. Martijn

Mayo Clinic

No container title available | June 30, 2020 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.22541/au.159352576.69683028 Get It

Background: Some long QT syndrome (LQTS) patients experience breakthrough cardiac events (BCEs) despite maximal therapy. Small studies have shown that intentional permanent atrial pacing (IPAP) is beneficial in refractory LQTS. As such, we sought to determine the genotype-specific utilization and efficacy of IPAP in a single-center LQTS registry. Methods and Results: In this retrospective study, electronic medical records from 1,065 LQTS patients were used to identify individuals that received IPAP. Pre- and post-IPAP heart rate, heart rate-corrected QT (QTc) values, annual BCE rate, and IPAP-related complications were compared between genotypes. BCEs were defined as LQTS-associated syncope/seizures, ventricular arrhythmia (VA)-terminating ICD therapies, and sudden cardiac arrest/death. Overall, 52/1065 LQTS patients received adjunctive IPAP therapy [77% female; median age 18.5 (IQR 1-35.5) years; 73% with prior VA]. Over an average IPAP follow-up of 121  82 months, the average heart rate increased from 65.8  20.4 bpm to 78.9  17.1 bpm; (p<0.01) and the average QTc decreased from 533.4  66.6 ms to 488.3  52.4 ms; (p<0.01). The mean BCE rate dropped from 0.88 to 0.19 per patient-year (p=0.01), driven by a marked decrease in LQT2 patients (1.01 BCE/year to 0.02 BCE/year; p=0.003). No serious IPAP-related complications were observed. Conclusion: In high-risk LQTS patients, namely those with recalcitrant LQT2, IPAP appears to be a safe and efficacious adjunct therapy. The beneficial effects of IPAP may stem from attenuating the QTc and circumventing a pause-dependent trigger. Whether IPAP might obviate the need for an ICD in some instances warrants further study.
Label-free proteomics reveals serum proteins whose levels differ between pancreatic ductal adenocarcinoma patients with short or long survival
Holm, Matilda , Saraswat, Mayank , Joenväärä, Sakari , Seppänen, Hanna , Renkonen, Risto, Haglund, Caj

Mayo Clinic

Tumor Biology | June 26, 2020 | Volume: 42 | Issue: 6 | Pages: No page available

10.1177/1010428320936410 | PMID 32586207 Get It

Pancreatic ductal adenocarcinoma is the most common and aggressive type of pancreatic cancer, with a 5-year survival rate that is less than 10%. New biomarkers to aid in predicting the prognosis of pancreatic ductal adenocarcinoma patients are needed. Previous proteomic studies have to a great extent focused on finding proteins of value for the diagnosis of pancreatic ductal adenocarcinoma. There is a lack of studies that have profiled the serum or plasma proteome in order to discover candidates for new prognostic biomarkers. In this study, we have used ultra-performance liquid chromatography–ultra-definition mass spectrometry to analyze the serum samples of 21 pancreatic ductal adenocarcinoma patients with short or long survival. Statistical analysis discovered 31 proteins whose expression differed significantly between pancreatic ductal adenocarcinoma patients with short or long survival. Pathway analysis discovered multiple canonical pathways enriched in this data set, with several pathways having roles in inflammation and lipid metabolism. The serum proteins identified here, which include complement components and several enzymes, could be of value as candidates for new noninvasive prognostic markers.
Effect of Anatomic Segment Involvement on Stereotactic Radiosurgery for Facial Nerve Schwannomas: An International Multicenter Cohort Study
Mehta, Gautam U. , Leković, Gregory P. , Slattery, William H. , Brackmann, Derald E., Long, Hao , Kano, Hideyuki , Mureb, Monica , Bernstein, Kenneth , Langlois, Anne-Marie, Mathieu, David , Nabeel, Ahmed M. , Reda, Wael A. , Tawadros, Sameh R. , Abdelkarim, Khaled , El-Shehaby, Amr M. N. , Emad, Reem M. , Mohammed, Nasser , Urgošík, Dušan, Liščák, Roman , Lee, Cheng‐Chia , Montazeripouragha, Amanallah , Joshi, Krishna C. , Barnett, Gene H. , Lunsford, L. Dade , Sheehan, Jason P. , Mehta, Gautam U , Mathieu, David , Kondziolka, Douglas , Langlois, Anne-Marie, Reda, Wael A. , Yang, Huai‐Che , Kaufmann, Anthony M. , Trifiletti, Daniel M.

Mayo Clinic

Neurosurgery | June 19, 2020 | Volume: 88 | Issue: 1 | Pages: E91-E98

10.1093/neuros/nyaa313 | PMID 32687577 Get It

Abstract BACKGROUND Facial nerve schwannomas are rare, challenging tumors to manage due to their nerve of origin. Functional outcomes after stereotactic radiosurgery (SRS) are incompletely defined. OBJECTIVE To analyze the effect of facial nerve segment involvement on functional outcome for these tumors. METHODS Patients who underwent single-session SRS for facial nerve schwannomas with at least 3 mo follow-up at 11 participating centers were included. Preoperative and treatment variables were recorded. Outcome measures included radiological tumor response and neurological function. RESULTS A total of 63 patients (34 females) were included in the present study. In total, 75% had preoperative facial weakness. Mean tumor volume and margin dose were 2.0 ± 2.4 cm 3 and 12.2 ± 0.54 Gy, respectively. Mean radiological follow-up was 45.5 ± 38.9 mo. Progression-free survival at 2, 5, and 10 yr was 98.1%, 87.2%, and 87.2%, respectively. The cumulative proportion of patients with regressing tumors at 2, 5, and 10 yr was 43.1%, 63.6%, and 63.6%, respectively. The number of involved facial nerve segments significantly predicted tumor progression ( P = .04). Facial nerve function was stable or improved in 57 patients (90%). Patients with involvement of the labyrinthine segment of the facial nerve were significantly more likely to have an improvement in facial nerve function after SRS ( P = .03). Hearing worsened in at least 6% of patients. Otherwise, adverse radiation effects included facial twitching (3 patients), facial numbness (2 patients), and dizziness (2 patients). CONCLUSION SRS for facial nerve schwannomas is effective and spares facial nerve function in most patients. Some patients may have functional improvement after treatment, particularly if the labyrinthine segment is involved.